Search Results 301-310 of 16794 for GLP-1 agonists

1. Pindolol (oral route) - Side effects & dosage - Mayo Clinic

   If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Acarbose; Aceclofenac; Acemetacin ...

2. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

   ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a ... 1 (LGI1) encephalitis. Participation eligibility. Participant ...

3. Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS) - Mayo Clinic

   About this study. This study is researching an experimental drug called REGN7544 (called "study drug"). The study is focused on participants with POTS.

4. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Clinical Trials · A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) ...

5. A Study to Evaluate the Safety and Effectiveness of BIIB054 in Subjects with Parkinson’s Disease - Mayo Clinic

   Use of any glucagon-like peptide-1 (GLP-1) agonists (e.g., exenatide, liraglutide, lixisenatide, albiglutide, and dulaglutide) within 90 days before Day 1.

6. AMBER-HFpEF: Assessment Of CK-4021586 In A Multi-Center, Blinded Evaluation Of Safety And Tolerability Results In HFpEF - Mayo Clinic

   ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after ... * Participants on a glucagon-like peptide-1 (GLP-1) agonist must be on a ...

7. A Study of Immune Cell Abnormalities Found in Individual Patients who have Type 1 Diabetes and are Waiting for Pancreas or Pancreas/Kidney Transplant Surgery - Mayo Clinic

   The purpose of this study is to measure and characterize specific immune cell abnormalities found in patients who have type 1 diabetes and may or may not be on ...

8. Clinical Trials - Type 1 Diabetes registry

   About this study. The purpose of this research is to create a single registry for type 1 and type 2 diabetes at Mayo Rochester and affiliated Mayo sites.

9. Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) - Mayo Clinic

   * Subjects in the non-pancreatic disease subgroup (i.e., T2DM) on longer acting agents, including thiazolidinediones and once-weekly GLP-1 agonists ...

10. Prolactinoma - Diagnosis & treatment - Mayo Clinic

    These medicines mimic the effects of dopamine. Dopamine is the brain chemical that controls how much prolactin the pituitary gland makes. Dopamine agonists can ...